Home

Stijg Lucky Monteur rbd serial Poland Brandweerman Notitie Oven

Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan | Nature Communications
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan | Nature Communications

SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination - Huang - 2020 - Advanced Materials - Wiley Online Library
SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination - Huang - 2020 - Advanced Materials - Wiley Online Library

Safety and potency of BIV1‐CovIran inactivated vaccine candidate for SARS‐CoV‐2: A preclinical study - Abdoli - 2022 - Reviews in Medical Virology - Wiley Online Library
Safety and potency of BIV1‐CovIran inactivated vaccine candidate for SARS‐CoV‐2: A preclinical study - Abdoli - 2022 - Reviews in Medical Virology - Wiley Online Library

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate - ScienceDirect
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate - ScienceDirect

Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display - ScienceDirect
Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display - ScienceDirect

SARS-CoV-2 S protein (319-541 aa) antibody (67758-1-Ig) | Proteintech
SARS-CoV-2 S protein (319-541 aa) antibody (67758-1-Ig) | Proteintech

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models | npj Vaccines
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models | npj Vaccines

Acta Crystallographica Section D: Vol 79, No 8
Acta Crystallographica Section D: Vol 79, No 8

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models - eBioMedicine
Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models - eBioMedicine

SARS-CoV-2 S protein (319-541 aa) antibody (67758-1-Ig) | Proteintech
SARS-CoV-2 S protein (319-541 aa) antibody (67758-1-Ig) | Proteintech

Viruses | Free Full-Text | Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
Viruses | Free Full-Text | Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity

Viruses | Free Full-Text | Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19
Viruses | Free Full-Text | Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19

Frontiers | Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine
Frontiers | Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine

Frontiers | Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron
Frontiers | Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose | Nature Communications
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose | Nature Communications

Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants | Nature Communications
Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants | Nature Communications

Competent immune responses to SARS-CoV-2 variants in older adults following two doses of mRNA vaccination | Nature Communications
Competent immune responses to SARS-CoV-2 variants in older adults following two doses of mRNA vaccination | Nature Communications

Luciferase-Based Biosensors in the Era of the COVID-19 Pandemic | ACS Nanoscience Au
Luciferase-Based Biosensors in the Era of the COVID-19 Pandemic | ACS Nanoscience Au

Frontiers | Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis
Frontiers | Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis

Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses | Nature Communications
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses | Nature Communications

Animals | Free Full-Text | Development of a Multispecies Double-Antigen Sandwich ELISA Using N and RBD Proteins to Detect Antibodies against SARS-CoV-2
Animals | Free Full-Text | Development of a Multispecies Double-Antigen Sandwich ELISA Using N and RBD Proteins to Detect Antibodies against SARS-CoV-2

Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants | Nature Communications
Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants | Nature Communications

Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases
Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis - Frontiers
Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis - Frontiers

Recombinant Anti-SARS-CoV-2 Spike RBD antibody [Abcam 2] - Rabbit IgG (Chimeric) (ab282039)
Recombinant Anti-SARS-CoV-2 Spike RBD antibody [Abcam 2] - Rabbit IgG (Chimeric) (ab282039)

Vaccines | December 2023 - Browse Articles
Vaccines | December 2023 - Browse Articles

Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants | Nature Communications
Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants | Nature Communications

Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] (ab283913)
Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] (ab283913)

Vaccines | Free Full-Text | Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
Vaccines | Free Full-Text | Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland

SARS-CoV-2 Spike S1 Protein ELISA Kit
SARS-CoV-2 Spike S1 Protein ELISA Kit

In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms | Cellular & Molecular Immunology
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms | Cellular & Molecular Immunology

Frontiers | Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
Frontiers | Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19

Mucosal SARS-CoV-2 vaccination of rodents elicits superior systemic T central memory function and cross-neutralising antibodies against variants of concern - eBioMedicine
Mucosal SARS-CoV-2 vaccination of rodents elicits superior systemic T central memory function and cross-neutralising antibodies against variants of concern - eBioMedicine

Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody | The Journal of Physical Chemistry B
Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody | The Journal of Physical Chemistry B

Mucosal SARS-CoV-2 vaccination of rodents elicits superior systemic T central memory function and cross-neutralising antibodies against variants of concern - eBioMedicine
Mucosal SARS-CoV-2 vaccination of rodents elicits superior systemic T central memory function and cross-neutralising antibodies against variants of concern - eBioMedicine

Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 (RBD) antibody [EPR24852-174] - BSA and Azide free (ab283947)
Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 (RBD) antibody [EPR24852-174] - BSA and Azide free (ab283947)

Frontiers | Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis
Frontiers | Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis

Self-replicating RNA nanoparticle vaccine elicits protective immune responses against SARS-CoV-2: Molecular Therapy - Nucleic Acids
Self-replicating RNA nanoparticle vaccine elicits protective immune responses against SARS-CoV-2: Molecular Therapy - Nucleic Acids

Pathogens | Free Full-Text | From Alpha to Delta—Genetic Epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland
Pathogens | Free Full-Text | From Alpha to Delta—Genetic Epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland

Vaccines | Free Full-Text | Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
Vaccines | Free Full-Text | Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees

Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody | The Journal of Physical Chemistry B
Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody | The Journal of Physical Chemistry B

SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination - Huang - 2020 - Advanced Materials - Wiley Online Library
SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination - Huang - 2020 - Advanced Materials - Wiley Online Library

Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8 | Virology Journal | Full Text
Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8 | Virology Journal | Full Text

Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody | The Journal of Physical Chemistry B
Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody | The Journal of Physical Chemistry B

Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 (RBD) antibody [EPR24852-174] (ab283946)
Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 (RBD) antibody [EPR24852-174] (ab283946)

Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates | Science Advances
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates | Science Advances

Vaccines | Free Full-Text | Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
Vaccines | Free Full-Text | Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees

SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination - Huang - 2020 - Advanced Materials - Wiley Online Library
SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination - Huang - 2020 - Advanced Materials - Wiley Online Library

Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan | Nature Communications
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan | Nature Communications